TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18540741

Group type: EXPERIMENTAL
Intervention: 1-session exposure-based treatment plus inactive pill with sedating herb description
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 1-session exposure-based treatment plus inactive pill with stimulating herb description
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 1-session exposure-based treatment plus inactive pill with placebo description
Number of subjects: 95

Group type: COMPARATOR
Intervention: 1-session exposure-based treatment
Number of subjects: 95

Group type: COMPARATOR
Intervention: waitlist condition
Number of subjects: 95

Group type: COMPARATOR
Intervention: psychological placebo condition
Number of subjects: 95
Study: 16106480

Group type: EXPERIMENTAL
Intervention: TAPP operation
Number of subjects: 1183

Group type: COMPARATOR
Intervention: Shouldice operation
Number of subjects: 1183
Study: 11988412

Group type: EXPERIMENTAL
Intervention: Reproductive and childhood social class variables
Number of subjects: 46
Study: 10082241

Group type: EXPERIMENTAL
Intervention: CCK4 (25 microg, i.v. injection)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 8851038

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg once a day
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study: 2261015

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide 0.1% cream with Duoderm dressing
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide 0.1% cream with Actiderm dressing
Number of subjects: 23
Study: 366723

Group type: EXPERIMENTAL
Intervention: Diflunisal 250 mg to 375 mg twice daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Aspirin 500 mg to 750 mg four times daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Diflunisal
Number of subjects: 30

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 30
Study: 31931888

Group type: EXPERIMENTAL
Intervention: Individualised pneumoperitoneum pressure strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional pneumoperitoneum pressure strategy
Number of subjects: 0
Study: 31260678

Group type: EXPERIMENTAL
Intervention: 37.5 mg prednisolone/d for 5 days
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 27442717

Group type: EXPERIMENTAL
Intervention: Graded motor imagery (GMI)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional rehabilitation (Control)
Number of subjects: 28
Study: 26025033

Group type: EXPERIMENTAL
Intervention: Prednisolone acetate 1%
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Diclofenac 0.1%
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 23485142

Group type: EXPERIMENTAL
Intervention: Buckwheat crackers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rice crackers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Buckwheat crackers (daily for 1 week)
Number of subjects: 0
Study: 21883530

Group type: EXPERIMENTAL
Intervention: Two fruit and nut bars totalling 1421.9 kJ (340 kcal) added to ad libitum diet
Number of subjects: 94
Study: 18178245

Group type: EXPERIMENTAL
Intervention: Intervention group (CHIP program)
Number of subjects: 348

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 348
Study: 17095445

Group type: EXPERIMENTAL
Intervention: Interprofessional education
Number of subjects: 0
Study: 15344469

Group type: EXPERIMENTAL
Intervention: Permutation tests for classification in image-based studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Testing on a hold-out set or cross-validation
Number of subjects: 0
Study: 10710121

Group type: EXPERIMENTAL
Intervention: Fluvastatin (40 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9106315

Group type: EXPERIMENTAL
Intervention: Surgery (Cloward technique)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 81

Group type: COMPARATOR
Intervention: Cervical collar
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: All groups (Surgery, Physiotherapy, Cervical collar)
Number of subjects: 81
Study: 1540093

Group type: EXPERIMENTAL
Intervention: Norfloxacin, 500-mg suspension every 8 hours, and nystatin, 1 million units every 6 hours
Number of subjects: 46

Group type: COMPARATOR
Intervention: Matching placebo solutions administered through a nasogastric tube
Number of subjects: 46
Study: 3895383

Group type: EXPERIMENTAL
Intervention: Endoscopists with knowledge of the radiological diagnosis
Number of subjects: 156

Group type: COMPARATOR
Intervention: Endoscopists without knowledge of the radiological diagnosis
Number of subjects: 156
Study: 30461166

Group type: EXPERIMENTAL
Intervention: Computerised interpretation of fetal heart rate patterns
Number of subjects: 46614
Study: 29706169

Group type: EXPERIMENTAL
Intervention: PNC-txt (text message-delivered Peer Network Counseling)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (waitlist)
Number of subjects: 30
Study: 25761488

Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m² intravenously every 3 weeks
Number of subjects: 95

Group type: COMPARATOR
Intervention: Gefitinib 250 mg/day orally
Number of subjects: 95
Study: 24651208

Group type: EXPERIMENTAL
Intervention: Pelvic osteotomy (OT) - 6 patients
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: No pelvic osteotomy (no-OT) - 13 patients
Number of subjects: 19

Group type: COMPARATOR
Intervention: Healthy control participants
Number of subjects: 19
Study: 21850515

Group type: EXPERIMENTAL
Intervention: Choice over treatment options (two pain-relieving treatments, same inert ointment mixture)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No choice over treatment options (two pain-relieving treatments, same inert ointment mixture)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (no treatment expectation)
Number of subjects: 0
Study: 19800671

Group type: EXPERIMENTAL
Intervention: MPCNL
Number of subjects: 165

Group type: COMPARATOR
Intervention: PCNL
Number of subjects: 165
Study: 16503029

Group type: EXPERIMENTAL
Intervention: Teflon prosthesis (Fluoroplastic piston)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Schuckneckt type piston wire/Teflon prosthesis
Number of subjects: 138
Study: 14642291

Group type: EXPERIMENTAL
Intervention: Experiment 1 - Children responded to a target within geometric categories, with varying locations.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experiment 2 - Multiple targets placed within each category at the same locations as Experiment 1.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experiment 3 - Children responded to one target more frequently than others.
Number of subjects: 0
Study: 10930905

Group type: COMPARATOR
Intervention: OAC (omeprazole 20 mg, amoxycillin 1500 mg, clarithromycin 600 mg for 7 days)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: OAC + CET (OAC plus cetraxate 600 mg for 7 days)
Number of subjects: 106
Study: 9283508

Group type: EXPERIMENTAL
Intervention: Matched services (at least 3 professional sessions directed at important employment, family, or psychiatric problems)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard treatment (treated in the usual manner)
Number of subjects: 94
Study: 8436150

Group type: EXPERIMENTAL
Intervention: isradipine SRO 5 mg once daily
Number of subjects: 37

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 37
Study: 2430269

Group type: EXPERIMENTAL
Intervention: Permethrin 1% creme rinse
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1% Lindane shampoo
Number of subjects: 0
Study: 31638977

Group type: EXPERIMENTAL
Intervention: Mobile learning readiness
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Attitude
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Behavioral control
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Subject norm
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Combined TPB structures (attitude, behavioral control, subject norm)
Number of subjects: 332
Study: 29402670

Group type: EXPERIMENTAL
Intervention: Multiple vessel (MV) group
Number of subjects: 78

Group type: COMPARATOR
Intervention: Single vessel (SV) group
Number of subjects: 78
Study: 26817533

Group type: EXPERIMENTAL
Intervention: levodopa‐carbidopa intestinal gel
Number of subjects: 167

Group type: COMPARATOR
Intervention: oral levodopa treatment
Number of subjects: 167
Study: 25359307

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (Yi‐Qi‐Jian‐Pi and Qu‐Tan‐Hua‐Zhuo granule) plus conventional medicine
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (Yi‐Qi‐Jian‐Pi and Qu‐Tan‐Hua‐Yu granule) plus conventional medicine
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo medicine plus conventional medicine
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: All groups (including both treatment and control)
Number of subjects: 240
Study: 22897374

Group type: EXPERIMENTAL
Intervention: 40 % O2 + 60 % N2O, 1‐2 % sevoflurane and 50 µg fentanyl + 2 mg vecuronium every 45 minutes
Number of subjects: 40

Group type: COMPARATOR
Intervention: 60 % dry air instead of 60 % N2O
Number of subjects: 40
Study: 20708634

Group type: EXPERIMENTAL
Intervention: Carriers with class S allele (L/S or S/S genotypes)
Number of subjects: 504

Group type: COMPARATOR
Intervention: Non-carriers (L/L genotype)
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: L/S genotype
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: S/S genotype
Number of subjects: 504
Study: 18826032

Group type: EXPERIMENTAL
Intervention: BioUD (7.75% 2-undecanone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 7% deet
Number of subjects: 0

Group type: COMPARATOR
Intervention: 15% deet
Number of subjects: 0
Study: 17186975

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 44

Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 44
Study: 12963549

Group type: EXPERIMENTAL
Intervention: Patients with CHI
Number of subjects: 22

Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 22
Study: 10693982

Group type: EXPERIMENTAL
Intervention: Quality control program for lipid testing at St. Paul's Hospital, UBC and NPHI, Helsinki.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality control program for triglyceride measurements at UBC and NPHI.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality control program for HDL measurements at UBC and NPHI.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality control program for apoprotein A‐1 measurements at both laboratories.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality control program for apoprotein B measurements at both laboratories.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DIAMAT assay for hemoglobin A‐1c at both laboratories.
Number of subjects: 0
Study: 9487427

Group type: EXPERIMENTAL
Intervention: Rifampicin containing short‐course antituberculosis regimens
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Baseline lymphocytes < 1200/microliters
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: CD4+ lymphocytes < 200/microliters
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Cavitary lung disease
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Atypical chest radiograph
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: PPD non‐reactivity
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: PPD non‐reactivity and non‐cavitary disease
Number of subjects: 49
Study: 8398959

Group type: EXPERIMENTAL
Intervention: 45 ml interscalene brachial plexus block with 1.5% mepivacaine, epinephrine, and bicarbonate
Number of subjects: 20

Group type: COMPARATOR
Intervention: 20 ml interscalene brachial plexus block with 1.5% mepivacaine, epinephrine, and bicarbonate
Number of subjects: 20
Study: 2439803

Group type: EXPERIMENTAL
Intervention: 10 mg bisoprolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 20 mg bisoprolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 mg atenolol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 12
Study: 29781549

Group type: EXPERIMENTAL
Intervention: Platelets administered before transport to surgery
Number of subjects: 122

Group type: COMPARATOR
Intervention: No platelets (control)
Number of subjects: 122
Study: 27842532

Group type: EXPERIMENTAL
Intervention: Silybin 94 mg + vitamin E 30 mg + phospholipids 194 mg
Number of subjects: 62

Group type: COMPARATOR
Intervention: Peg‐IFN plus RBV
Number of subjects: 62
Study: 23867557

Group type: EXPERIMENTAL
Intervention: 5 Hz TMS to the right primary motor cortex (M1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 0
Study: 23742725

Group type: EXPERIMENTAL
Intervention: High-molecular-weight barley β-glucan (HBG)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight barley β-glucan (LBG)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control soup with no barley β-glucan (CHO)
Number of subjects: 15
Study: 20562409

Group type: EXPERIMENTAL
Intervention: Pulpotomy with calcium‐enriched mixture (PCEM), n = 205
Number of subjects: 407

Group type: COMPARATOR
Intervention: One-visit root canal therapy (ORCT), n = 202
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Pulpotomy with calcium‐enriched mixture (PCEM)
Number of subjects: 407

Group type: COMPARATOR
Intervention: One-visit root canal therapy (ORCT)
Number of subjects: 407
Study: 18091041

Group type: EXPERIMENTAL
Intervention: Three-component intervention including e-mail memoranda, a Web site, and a handheld computer program.
Number of subjects: 16500

Group type: COMPARATOR
Intervention: Control hospitals (remaining hospitals in the county).
Number of subjects: 16500
Study: 16398773

Group type: EXPERIMENTAL
Intervention: 400 microg oral misoprostol
Number of subjects: 338

Group type: COMPARATOR
Intervention: 400 microg self-administered vaginal misoprostol
Number of subjects: 338
Study: 12927624

Group type: EXPERIMENTAL
Intervention: Liquid formula diet with long-chain triglycerides (LCT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Liquid formula diet with medium-chain triglycerides (MCT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Alfentanil (4.1 +/- 0.5 mg) administered for 90 min
Number of subjects: 10
Study: 10807893

Group type: EXPERIMENTAL
Intervention: 1.5 kcal/ml nutritional supplement
Number of subjects: 101

Group type: COMPARATOR
Intervention: Routine nutritional management (Control)
Number of subjects: 101
Study: 8795595

Group type: EXPERIMENTAL
Intervention: 3 MIU of interferon-beta-1a
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 9 MIU of interferon-beta-1a
Number of subjects: 68
Study: 1516606

Group type: EXPERIMENTAL
Intervention: levodopa
Number of subjects: 8

Group type: COMPARATOR
Intervention: absence of levodopa
Number of subjects: 8
Study: 6736345

Group type: EXPERIMENTAL
Intervention: Maximally aggressive erythemogenic UVB (MAEUVB) schedule
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Suberythemogenic UVB (SEUVB) schedule
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical treatment with 2% crude coal tar ointment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ointment vehicle
Number of subjects: 0
Study: 31887854

Group type: EXPERIMENTAL
Intervention: BEYNEX (web-based program)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Rivastigmine patch (10 cm² = 9.5 mg)
Number of subjects: 120
Study: 27634952

Group type: EXPERIMENTAL
Intervention: IV tissue plasminogen activator plus Solitaire stent retriever
Number of subjects: 69
Study: 25670764

Group type: EXPERIMENTAL
Intervention: pegylated liposomal doxorubicin (30 mg/m²) followed by carboplatin (AUC 5 mg min/ml) every 28 days
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: pegylated liposomal doxorubicin and carboplatin
Number of subjects: 35
Study: 23792243

Group type: EXPERIMENTAL
Intervention: Child selective attention to pain (dot-probe task)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Parental characteristics (rumination and helplessness)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Child attentional avoidance
Number of subjects: 59
Study: 21668741

Group type: EXPERIMENTAL
Intervention: Morphine (0.08 mg/kg)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Butorphanol (0.016 mg/kg)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 142
Study: 19526210

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 1024

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 1024
Study: 17005060

Group type: EXPERIMENTAL
Intervention: Mask PEP
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: NPPV
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control treatment (directed cough)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: NPPV and CPAP
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Mask PEP, CPAP, NPPV
Number of subjects: 17
Study: 15383185

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study: 12024755

Group type: EXPERIMENTAL
Intervention: Suction-type aerosol reduction device (ARD)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine gluconate (CHX) antimicrobial rinse
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combination of ARD and CHX rinse
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 15
Study: 9263319

Group type: EXPERIMENTAL
Intervention: Hydrocortisone 2.5% cream once daily + water-in-oil cream once daily
Number of subjects: 25

Group type: COMPARATOR
Intervention: Hydrocortisone 2.5% cream twice daily
Number of subjects: 25
Study: 8500857

Group type: COMPARATOR
Intervention: KCl infusions (0.12 and 0.24 mEq/min) with ouabain (2 micrograms/min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: KCl infusions (0.12 and 0.24 mEq/min) after salt loading (180 mEq NaCl for 7 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium nitroprusside and verapamil
Number of subjects: 0
Study: 3791366

Group type: EXPERIMENTAL
Intervention: Fiorinal with Codeine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fiorinal alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Codeine alone
Number of subjects: 0
Study: 30849351

Group type: EXPERIMENTAL
Intervention: Silver nylon dressing
Number of subjects: 657

Group type: COMPARATOR
Intervention: Gauze dressing
Number of subjects: 657
Study: 28433895

Group type: EXPERIMENTAL
Intervention: peer educator network‐oriented intervention
Number of subjects: 232

Group type: COMPARATOR
Intervention: standard of care control arm
Number of subjects: 232
Study: 24957977

Group type: EXPERIMENTAL
Intervention: 20 min repetitive typing task
Number of subjects: 24

Group type: COMPARATOR
Intervention: 20 min mental recitation (control)
Number of subjects: 24
Study: 24037566

Group type: EXPERIMENTAL
Intervention: Open surgical repair (OR)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Endovascular repair (EVAR)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Overall group (OR + EVAR)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Comparison between OR and EVAR
Number of subjects: 189
Study: 22123319

Group type: EXPERIMENTAL
Intervention: Ipilimumab 3 mg/kg
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Ipilimumab 10 mg/kg
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Ipilimumab (both doses)
Number of subjects: 82
Study: 19903780

Group type: EXPERIMENTAL
Intervention: GM-CSF (110 microg) with multipeptide vaccine
Number of subjects: 121

Group type: COMPARATOR
Intervention: Multipeptide vaccine without GM-CSF
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Multipeptide vaccine with GM-CSF
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Disease-free survival
Number of subjects: 121
Study: 16518754

Group type: EXPERIMENTAL
Intervention: Pegylated IFN‐alpha 2a and ribavirin combination therapy
Number of subjects: 0
Study: 15542102

Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis LKM512 yogurt (100g/day for 2 weeks)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (100g/day for 2 weeks)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Comparison of LKM512 yogurt vs. placebo
Number of subjects: 7
Study: 12184546

Group type: EXPERIMENTAL
Intervention: Active vitamin D treatment (VD(+))
Number of subjects: 63

Group type: COMPARATOR
Intervention: No treatment (VD(-))
Number of subjects: 63
Study: 9640634

Group type: EXPERIMENTAL
Intervention: Standard-plus-innovative intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard intervention
Number of subjects: 0
Study: 7867317

Group type: EXPERIMENTAL
Intervention: CCMD-2
Number of subjects: 254

Group type: COMPARATOR
Intervention: DSM-III-R
Number of subjects: 254
Study: 2801579

Group type: EXPERIMENTAL
Intervention: Protein diet (400 kcal/d, 13.2 g nitrogen, 23 mmol potassium)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Glucose diet (400 kcal/d, 16 mmol potassium chloride, multivitamin supplement)
Number of subjects: 11
Study: 1102148

Group type: EXPERIMENTAL
Intervention: Betamethasone valerate aerosol (100 mug into each nostril twice daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 31516032

Group type: EXPERIMENTAL
Intervention: Glasdegib 100 mg once daily plus low-dose cytarabine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glasdegib plus cytarabine and daunorubicin (7 + 3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glasdegib plus azacitidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus low-dose cytarabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus cytarabine and daunorubicin (7 + 3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus azacitidine
Number of subjects: 0
Study: 27519188

Group type: EXPERIMENTAL
Intervention: Immediate loading using ball attachments (Group A)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Delayed loading after 3 months (Group B)
Number of subjects: 155
Study: 25967143

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 1943

Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 1943

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1943

Group type: EXPERIMENTAL
Intervention: Sunitinib and Sorafenib
Number of subjects: 1943

Group type: EXPERIMENTAL
Intervention: Sunitinib, Sorafenib, and Placebo
Number of subjects: 1943